Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mercedes Robles

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Journal of Hepatology|February 4, 2021
Comprehensive analysis and insights gained from long-term experience of the Spanish DILI RegistryCamilla Stephens, Mercedes Robles-Diaz, Inmaculada Medina-Caliz, et al.
Journal of Hepatology|October 6, 2023
Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitisFrancesca Colapietro, Patrick Maisonneuve, Ellina Lytvyak, et al.
JHEP Reports : Innovation in Hepatology|May 17, 2021
Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injuryPaula Iruzubieta, Naroa Goikoetxea-Usandizaga, Lucía Barbier-Torres, et al.
Nature Communications|March 3, 2023
Tandem mass tag-based quantitative proteomic profiling identifies candidate serum biomarkers of drug-induced liver injury in humansKodihalli C Ravindra, Vishal S Vaidya, Zhenyu Wang, et al.
Diagnostic and Prognostic Research|September 12, 2023
Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case-control studyJane I Grove, Camilla Stephens, M Isabel Lucena, et al.
Journal of Hepatology|May 18, 2016
Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injuryInmaculada Medina-Caliz, Mercedes Robles-Diaz, Beatriz Garcia-Muñoz, et al.
Ebiomedicine|March 25, 2026
Usefulness of plasma bile acid profile as a prognostic biomarker for drug-induced liver injuryMaria J Monte, Thi Dong-Binh Tran, Jane I Grove, et al.
Journal of Hepatology|May 10, 2023
Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting reportRaúl J Andrade, Guruprasad P Aithal, Ynto S de Boer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 11, 2024
Drug-induced Liver Injury in Latin America: 10-year Experience of the Latin American DILI (LATINDILI) NetworkFernando Bessone, Nelia Hernandez, Inmaculada Medina-Caliz, et al.
Journal of Hepatology|May 31, 2024
Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantationAldo J Montano-Loza, Ellina Lytvyak, Gideon Hirschfield, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Journal of Hepatology|February 4, 2021
Comprehensive analysis and insights gained from long-term experience of the Spanish DILI RegistryCamilla Stephens, Mercedes Robles-Diaz, Inmaculada Medina-Caliz, et al.
Journal of Hepatology|October 6, 2023
Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitisFrancesca Colapietro, Patrick Maisonneuve, Ellina Lytvyak, et al.
JHEP Reports : Innovation in Hepatology|May 17, 2021
Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injuryPaula Iruzubieta, Naroa Goikoetxea-Usandizaga, Lucía Barbier-Torres, et al.
Nature Communications|March 3, 2023
Tandem mass tag-based quantitative proteomic profiling identifies candidate serum biomarkers of drug-induced liver injury in humansKodihalli C Ravindra, Vishal S Vaidya, Zhenyu Wang, et al.
Diagnostic and Prognostic Research|September 12, 2023
Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case-control studyJane I Grove, Camilla Stephens, M Isabel Lucena, et al.
Journal of Hepatology|May 18, 2016
Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injuryInmaculada Medina-Caliz, Mercedes Robles-Diaz, Beatriz Garcia-Muñoz, et al.
Ebiomedicine|March 25, 2026
Usefulness of plasma bile acid profile as a prognostic biomarker for drug-induced liver injuryMaria J Monte, Thi Dong-Binh Tran, Jane I Grove, et al.
Journal of Hepatology|May 10, 2023
Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting reportRaúl J Andrade, Guruprasad P Aithal, Ynto S de Boer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 11, 2024
Drug-induced Liver Injury in Latin America: 10-year Experience of the Latin American DILI (LATINDILI) NetworkFernando Bessone, Nelia Hernandez, Inmaculada Medina-Caliz, et al.
Journal of Hepatology|May 31, 2024
Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantationAldo J Montano-Loza, Ellina Lytvyak, Gideon Hirschfield, et al.
Pageof 8